# Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Clarithromycin, Amoxicillin and Ilaprazole

> **NCT02998437** · PHASE1 · COMPLETED · sponsor: **Il-Yang Pharm. Co., Ltd.** · enrollment: 28 (actual)

## Conditions studied

- Drug Interaction Potentiation

## Interventions

- **DRUG:** Ilaprazole 10mg
- **DRUG:** Clarithromycin 500mg
- **DRUG:** Amoxicillin 500 Mg

## Key facts

- **NCT ID:** NCT02998437
- **Lead sponsor:** Il-Yang Pharm. Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2017-01-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02998437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02998437, "Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Clarithromycin, Amoxicillin and Ilaprazole". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02998437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*